New insider activity at Encompass Health ( (EHC) ) has taken place on August 27, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EVP & COO Patrick William Tuer recently sold 1,020 shares of Encompass Health stock, amounting to a total transaction value of $126,061.
Recent Updates on EHC stock
Encompass Health has seen a positive shift in its stock price targets, with analysts at Truist and UBS raising their targets to $140, citing strong financial performance and growth potential. The company reported a significant increase in net operating revenue and adjusted earnings per share in its Q2 2025 results, driven by a rise in total discharges and net patient revenue per discharge. Encompass Health’s strategic expansion plans, including the construction of new inpatient rehabilitation hospitals in Texas, further bolster its growth outlook. Analysts highlight robust fundamentals, ongoing labor improvements, and increased investment in artificial intelligence as key factors supporting their bullish stance.
Spark’s Take on EHC Stock
According to Spark, TipRanks’ AI Analyst, EHC is a Outperform.
Encompass Health’s strong financial performance, particularly in revenue and EBITDA growth, is a major positive factor. The technical indicators support a bullish trend, though caution is advised due to potential overbought conditions. Valuation is moderate, and the earnings call provided a positive outlook despite some operational challenges.
To see Spark’s full report on EHC stock, click here.
More about Encompass Health
YTD Price Performance: 32.69%
Average Trading Volume: 854,978
Technical Sentiment Signal: Buy
Current Market Cap: $12.28B